# A Delayed Adverse Reaction: Hydralazine-Induced Lupus After Years of Use

**Authors:** Saurav Paudel, Ayushma Acharya, Sanjiv Poudel, Swarup Sharma Rijal

PMC · DOI: 10.7759/cureus.87514 · 2025-07-08

## TL;DR

A 61-year-old woman developed lupus-like symptoms after years of hydralazine use, which resolved after stopping the drug and starting treatment.

## Contribution

This case highlights hydralazine-induced lupus can develop years after drug exposure and be successfully treated.

## Key findings

- Symptoms resolved after discontinuing hydralazine and starting corticosteroids and methotrexate.
- Anti-nuclear antibody and anti-histone antibodies confirmed drug-induced lupus.
- A false-positive Lyme antibody test complicated the diagnosis.

## Abstract

Drug-induced lupus (DIL) is a rare autoimmune condition triggered by certain medications, most commonly hydralazine and procainamide. DIL can manifest after a few weeks or even after several years of drug exposure. We present a case of a 61-year-old female with hypertension and type 2 diabetes mellitus who developed progressive polyarthritis, myalgia, and fatigue that developed over a year after three years of hydralazine use. Laboratory findings revealed anemia, leukopenia, elevated inflammatory markers, an anti-nuclear antibody (ANA) titer of 1:2560, and anti-histone antibodies of 4.9 units. A false-positive immunoglobulin M (IgM) Lyme antibody complicated the diagnostic workup. Discontinuation of hydralazine and initiation of corticosteroid and methotrexate resulted in resolution after six weeks, confirming the diagnosis of hydralazine-induced lupus.

## Linked entities

- **Chemicals:** hydralazine (PubChem CID 3637), methotrexate (PubChem CID 4112)
- **Diseases:** type 2 diabetes mellitus (MONDO:0005148), lupus (MONDO:0004670)

## Full-text entities

- **Diseases:** autoimmune condition (MESH:D001327), polyarthritis (MESH:D001168), hypertension (MESH:D006973), fatigue (MESH:D005221), type 2 diabetes mellitus (MESH:D003924), myalgia (MESH:D063806), leukopenia (MESH:D007970), anemia (MESH:D000740), DIL (MESH:D000081015), Lupus (MESH:D008180), inflammatory (MESH:D007249)
- **Chemicals:** methotrexate (MESH:D008727), Hydralazine (MESH:D006830), procainamide (MESH:D011342)

---
Source: https://tomesphere.com/paper/PMC12330299